Dr. Kathleen Stergiopoulos, MD

Dr. Stergiopoulos practices at St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre.

Dr. Stergiopoulos' NPI, 1457465023, was assigned on August 19, 2006. Dr. Stergiopoulos graduated from SUNY Upstate Medical University in 2000. Dr. Stergiopoulos holds New York license 236751.

Dr. Stergiopoulos' primary practice is St. Francis Hospital & Heart Center, at 100 Port Washington Boulevard, Roslyn, NY 11576 in Nassau County. The practice phone is (516) 562-6000.

Dr. Stergiopoulos' primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. Dr. Stergiopoulos is also affiliated with Stony Brook University Hospital. The medical group on file is Cardiac Interventional Group. Dmand AI also links Dr. Stergiopoulos to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stergiopoulos practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Stergiopoulos' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Stergiopoulos is licensed in New York.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension and coronary artery disease among the conditions Dr. Stergiopoulos treats.

CMS data shows 4,399 Medicare services from Dr. Stergiopoulos across 22 procedure codes in 2024, for 1,620 Medicare patients. Medicare paid $356,696 for them.

CMS counts 1,620 Medicare patients who saw Dr. Stergiopoulos in 2024. The largest group is 75 to 84, with 679 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stergiopoulos' median patient age at 67, with 51% women.

In 2024, Dr. Stergiopoulos wrote 3,200 Medicare Part D claims for 388 patients. 88% of them were for generic drugs. CMS names the drug for 2,941 of them, across 39 drugs with 11 or more claims each, at $492,909 in total drug cost. In 2023, CMS named 1,929 claims across 30 drugs.

Dr. Stergiopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 44 papers to Dr. Stergiopoulos, published from 2008 to 2021. 2017 was the busiest year, with 3. The most frequent topics are Pregnancy Complications, Cardiovascular, Pregnancy Outcome and Hospital Mortality. Dr. Stergiopoulos has published most often in Acute Card Care. Dr. Stergiopoulos' most frequent co-authors are Fabio Vasconcelos Lima, MD, Cecilia Avila, MD and Paraskevi Koutrolou-Sotiropoulou, MD.

CMS Open Payments shows 48 general payments to Dr. Stergiopoulos from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $250.

Dmand AI lists 8 awards for Dr. Stergiopoulos, most recently Co-Director, Women’s Cardiovascular Services in 2019.

Dr. Stergiopoulos graduated from SUNY Upstate Medical University in 2000.

Dr. Stergiopoulos is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.